New study aims to predict who gets liver cancer from alcohol

NCT ID NCT07272200

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks at 1,000 people with alcohol-related liver disease to understand how their genes and drinking habits together raise the risk of liver cancer. Researchers will analyze DNA and lifestyle factors to create a risk score that could help doctors decide who needs regular screening. The goal is to catch cancer earlier and save lives.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this could lead to a risk score that identifies people most likely to develop liver cancer from alcohol, enabling earlier screening and prevention.
What could go wrong
This is an observational study, not a treatment trial. It may not find clear genetic links, and any risk score would need years of validation before clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRYPTOGENIC LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Istituto di Ricovero e Cura a Carattere Scientifico di natura pubblica

    RECRUITING

    Milan, Milano, 20122, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.